MTIP
PETX

Magee Thomson Investment Partners’s Aratana Therapeutics, Inc. PETX Stock Holding History

Magee Thomson Investment Partners’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-295
Closed -$3K – 115
2015
Q3 		$3K Buy
+295
New +$4.99K ﹤0.01% 101

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Magee Thomson Investment Partners's PETX Position: Q4 2015 in Review

Magee Thomson Investment Partners sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 295 shares — an estimated $3K sold.

Magee Thomson Investment Partners first reported a position in PETX in Q3 2015 and held it in 1 quarter. The position peaked at $3K in Q3 2015. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

  • Magee Thomson Investment Partners reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 295 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $3K.
  • Magee Thomson Investment Partners first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 1 quarter.
  • Magee Thomson Investment Partners's Aratana Therapeutics, Inc. position peaked at $3K in Q3 2015.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on Magee Thomson Investment Partners's 13F filing for Q4 2015, filed 26 Jan 2016.